ZSWIM4: A Potential Drug Target and Biomarker for Zinc Finger SWIM-Type

Target Name: ZSWIM4

NCBI ID: G65249

ZSWIM4

ZSWIM4: A Potential Drug Target and Biomarker for Zinc Finger SWIM-Type

Zinc finger SWIM-type (ZFS) is a gene mutation that has been identified in various organisms, including humans. It is characterized by the absence of a specific protein gene, which leads to the production of a specific protein that is not functional. In some cases, this gene mutation can cause a genetic disorder known as zinc finger SWIM-type syndrome.

ZSWIM4 is a specific ZFS gene mutation that has been identified in humans. It is a single nucleotide polymorphism (SNP) that results in the substitution of a thymine (T) for a guanine (G) at position 618. This SNP has been shown to cause a specific protein that is not functional.

Research has suggested that ZSWIM4 may be a potential drug target and biomarker for various diseases. For example, ZSWIM4 has been shown to be involved in a variety of cellular processes, including cell signaling, DNA replication, and metabolism. It has also been shown to be involved in the development and progression of various diseases, including cancer.

One potential mechanism by which ZSWIM4 may be involved in the development and progression of cancer is its role in cell signaling. ZSWIM4 has been shown to be involved in the regulation of various cellular signaling pathways, including the TGF-β pathway. This pathway is known to play a role in the development and progression of cancer, and it is possible that ZSWIM4 may be involved in the regulation of this pathway.

Another potential mechanism by which ZSWIM4 may be involved in the development and progression of cancer is its role in DNA replication. ZSWIM4 has been shown to be involved in the regulation of DNA replication, and it is possible that this mutation may be involved in the development and progression of cancer by affecting the replication of DNA.

In addition to its potential role in cancer development, ZSWIM4 has also been suggested as a potential biomarker for this disease. The absence of the functional protein gene associated with ZSWIM4 has been shown to be associated with various cellular and molecular changes that are associated with cancer. For example, ZSWIM4 has been shown to be involved in the regulation of cell apoptosis, which is a process by which cells die naturally in response to various stimuli. It is possible that ZSWIM4 may be involved in the regulation of cell apoptosis and that this mutation may be associated with an increased risk of cancer.

In conclusion, ZSWIM4 is a specific ZFS gene mutation that has been identified in humans. It has been shown to be involved in various cellular processes and has been suggested as a potential drug target and biomarker for various diseases, including cancer. Further research is needed to fully understand the role of ZSWIM4 in these diseases and to develop effective treatments.

Protein Name: Zinc Finger SWIM-type Containing 4

The "ZSWIM4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZSWIM4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets